DXCM Q2 2022 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$696M+17.0% YoY

Gross Profit

$450M64.6% margin

Operating Income

$77M11.1% margin

Net Income

$51M7.3% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

+10.7%

Cash Flow

Operating Cash Flow

$173M

Free Cash Flow

$81M

Stock-Based Comp.

$33M

Balance Sheet

Total Assets

$5.2B

Total Liabilities

$3.0B

Stockholders' Equity

$2.3B

Cash & Equivalents

$735M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$696M	$595M	+17.0%
Gross Profit	$450M	$417M	+7.8%
Operating Income	$77M	$101M	-23.8%
Net Income	$51M	$63M	-19.1%

Geographic Segments

UNITED STATES

$511M73%

Non-US

$185M27%